| Literature DB >> 26791091 |
Inge Schmitz-Feuerhake1, Christopher Busby2, Sebastian Pflugbeil3.
Abstract
OBJECTIVES: To investigate the accuracy and scientific validity of the current very low risk factor for hereditary diseases in humans following exposures to ionizing radiation adopted by the United Nations Scientific Committee on the Effects of Atomic Radiation and the International Commission on Radiological Protection. The value is based on experiments on mice due to reportedly absent effects in the Japanese atomic bomb (Abomb) survivors.Entities:
Keywords: Congenital malformation; Down´s syndrome; Environmental radioactivity; Internal radiation; Low level effects; Sex-ratio; Still birth
Year: 2016 PMID: 26791091 PMCID: PMC4870760 DOI: 10.5620/eht.e2016001
Source DB: PubMed Journal: Environ Health Toxicol ISSN: 2233-6567
Increase of congenital malformations after exposure by the Chernobyl accident
| Country and region | Study | Details | Estimated dosesa 1 yr (mSv) adult | Reference |
|---|---|---|---|---|
| Europe wide | ||||
| UNSCEAR | Review | Concludes: “conflicting results"; “no changes in birth defects could be related to ionizing radiation" mainly on basis of a lack of biological gradient | Nationwide 1 yr doses: 0.2-10 mSv | UNSCEAR 2000 [ |
| Mainly based on external Cs-137 | UNSCEAR 2006 [ | |||
| Review by Little | Review | Largely as above | ||
| EUROCAT study 16 regions of Europe | 16 EUROCAT registries: Down’s syndrome, NTD, hydrocephaly, microcephaly, arhinecephaly, an/micropthalmia, congenital cataract | 3 Cohort periods; 231401 births in 1986; authors concluded no effect apparent; but examination of data presented shows excess risk for all but Down’s syndrome in both assumed exposed cohorts relative to assumed non-exposed cohort; for 1987 vs. 1988/1989 OR 1.2 (95% Cl, 1.02-1.4), | High | Dolket al. 1999 [ |
| External Cs-137 | ||||
| Review by Hoffmann | Down’s syndrome, NTD, cleft palate, other malformations | Review of studies from Turkey, Bulgaria, Croatia, Germany, Belarus, Finland, Norway, EUROCAT registries; guestions established risk coefficients and linear dose response on basis of observations | 0.1-0.5 mSv | Hoffmann 2001 [ |
| Belarus | ||||
| National Genetic | Anencephaly, spina bifida, cleft lip and/or palate, polydactyly, limb reduction defects, esophageal atresia, anorectal atresia, Down’s syndrome, multiple malformations | 1. Pathologies of legal medical abortuses | Based on Cs-137 area contamination 1 yr external dose | Lazjuk et al. 1997 [ |
| Monitoring Registry | Total congenital malformation increase 1987-1994 vs. 1982-1985 in three regions defined by Cs-137 contamination; >555 kBq/m2=81%, n=151- 381, | Internal Cs-137 annual adult dose on basis of Polissia highest contamination area | ||
| Wertelecki is 1 mSv Cs-137 and 2 mSv Sr-90 (ICRP 72 ingestion) | ||||
| >37 kBq/m2=49%, n=899-2180, | UN estimates 2 mSv first year dose for all Belarus | |||
| Control <37 kBq/m2=43%; n=255-649, | ||||
| Excluded teratogenic effects; cannot exclude selection bias as analysis of unreportable abortuses not possible; Down’s syndrome increase in lower dose regions not high dose region | ||||
| 2. Congenital malformation in neonates | ||||
| Whole of Belarus; increase in frequency of congenital malformation from 12.5/1000 in 1985 to 17.7 /1000 in 1994; increasing risks stabilized by abortions at upper level due to State intervention program | ||||
| National Genetic | 1. Chromosome aberrations | 1. 1986-1988 mean Dicentric and Ring chromosome anomaly (CA) | As above | Feshchenko et al. 2002 [ |
| Monitoring Registry | Contaminated region (Gomel and Mogilev) n=91; CA=0.39+-0.09%; (>555 kBq/m2) | Total annual effective dose | ||
| 2. Strict Registration of Malformations System | Control region (Minsk, Grodno, Novopolotsk) n=118; CA = 0.09+-0.04 | |||
| 2. Human embryos aborted foetus | Dose to ovaries is the same as effective dose | |||
| Same list of malformations as a Lazjuk; increase rate 1982-1985 to 1987-1996 is 86% in contaminated regions and 59% in control regions, | ||||
| Highly exposed region of Gomel | Congenital malformations | 1. Mortality in children 0-4 High exposure Gomel vs. low exposure Vitebsk 1994; absolute rates Gomel 4.1% vs. Vitebsk 3% | Annual doses | Bogdanovich 1997 [ |
| 2. “Frequency of CM reflects environmental pollution level" | ||||
| Increased frequency of malformations per 1000 births in Gomel contaminated territories 1982-1985 to 1987-1989: | ||||
| Vetka 560%, Dobrush 170%, Khoiniki 230%, Chechersk 680%, and Elsk 200%; all Belarus less the contaminated areas 120% | ||||
| Chechersky district (Gomel) | Congenital malformations | Investigation of 688 pregnancies and 7000 births in Chechersky (Gomel, Belarus) and Polessky (Kiev, Ukraine); sharp reductions in birth rates in both regions after Chernobyl ascribed partly to abortions; high perinatal mortality ascribed partly to congenital malformations; “incidence increased by a factor of 2 following the accident"; congenital heart disease, esophageal atresia, anencephaly, hydrocephaly and multiple malformations; total number of neonatal disorders increase in Plessky from 1983-1985 to 1986-1990 from 6.81 to 21.32 (313%) and in Chechersky from 5.15 to 10.49; no statistical data given | Annual doses | Kulakov et al. 1993 [ |
| Mogilev Region | Congenital malformations | Retrospective analysis of all pregnanciesl 981 -1993 in high exposed Mogilev and Gomel vs. low exposed Brest and Vitebsk; excess CM in high exposure areas relative low exposure areas; CM rates increased before vs after: Gomel 150%, Mogilev 130%, Brest 120%, and Vitebsk 110% in rank of contamination; no statistical analysis | Annual doses | Petrova et al. 1997 [ |
| Brest region | Congenital malformations | See above | See above | Shidlovskii et al. 1992 [ |
| Ukraine | ||||
| Polissia region (Rivne) | 8 Core EUROCAT defined malformations. Polissia vs.non-Polissiawith whole body monitoring 2000-2009 | Polissia is region of Chernobyl contaminated Pripyat marshes; study of EUROCAT defined core malformations between two regions with whole body monitoring Cs-137 levels of Polissia 557 kBg, non-Polissia 155 kBg, 145437 live births; for 2000-2004 rates per 1000 births, NTD OR 1.59 ( | Key study for assessing risk coefficient External cumulative doses | Wertelecki et al. 2010, 2014 [ |
| See text for discussion | Internal cumulative doses | |||
| Total | ||||
| Polessky region (Kiev) | Congenital malformations | See Chechersky above | See above | Kulakov et al. 1993 [ |
| Lugyny region | Congenital malformations | Godlevsky et al. 1998 [ | ||
| Turkey | ||||
| Bursa region | Anencephaly, spina bifida | Population of 90000 persons in Bursa region; rates increased from 1.7 to 9.2 NTD per 1000 births before Chernobyl to 20 in the first 6 mo of 1987 (n=12); most pronounced for anencephalus which increased 5-fold (n=6) | <0.5mSv | Akar et al. 1989 [ |
| Aegean Turkey; Izmir | Anencephaly, spina bifida | 19115 Births in Izmir hospital Jun 1986-Jul 1988 rate of NTD before Chernobyl=1.9 per 1000 births; in May, Jun, Jul increased to 8.9 per 1000 births and subseguently returned to normal in 9 mo | <0.5mSv | Caglayan et al. 1989 [ |
| Eastern Turkey; Elazig | Anencephaly, spina bifida | Prospective study 1985-1990, 5240 births rate prior to Chernobyl of NTD plus anencephaly 1.7 per 1000 (1.5 anencephaly); following Chernobyl became 6.9 per 1000 (5.5 anencephaly); peaked at 12.4 (8.9) in 1988 falling to 5.6 (4.2) in 1990 | <0.5mSv | Giivenc et al. 1993 [ |
| Eastern Black Sea region Ankara | Anencephaly, spina bifida | 40997 Births; 1981-1986 NTD rates for NTD 2.12 per 1000 births and anencephaly 1.29 per 1000 births; after Chernobyl=4.39 and 2.46, | <0.5mSv | Mocan et al. 1990 [ |
| Bulgaria | ||||
| Pleven region | Malformation of heart and central nervous system, multiple malformations | “Significant increases after Chernobyl" guoted in Hoffmann 2001; no details of numbers | <0.8mSv | Moumdjievet al. 1992 [ |
| Croatia | Malformations by autopsy of stillbirth and neonatal death (perinatal) | 3451 Perinatal autopsies at Zagreb Hospital; “increased freguencies in post-Chernobyl period"; no statistical data | <0.5 mSv | Kruslin et al. 1998 [ |
| Germany | ||||
| German Democratic Republic | CLP | Influence of radiation levels on CLP in newborns in former GDR 1980-1989; significant prevalence increase found in 1983 (F1 weapons fallout?) 1987 and 1988; 1987 showed an increase of 9.4% over mean rate since 1980; effect highest in areas with highest Cs-137 and Sr-90; all increases significant at the 5% level; levels of Cs-137 in Berlin measured at 6 kBg/m2 | <0.3 mSv | Zieglowski et al. 1999 [ |
| Bavaria | CLP | In Bavaria CLP increased 9.5% from Oct 1986 to Dec 1990 relative to previous trend; | <0.3 mSv | Scherb et al. 2004 [ |
| Bavaria | Congenital malformations | For each Bavarian district (n=96) the ratio of the rates, more precisely the ORs, are calculated; results are regressed on surface contamination and show a biphasic relationship at low doses | <0.3 mSv | Koerblein 2004 [ |
| West Berlin | Malformations of stillborns | No increase of cases with malformations in living births but an increase of the rate of malformations in stillbirths - 4.2 % in 1986, and 8.5 % in 1987 which is remarkable, because West Berlin had a nearly completely isolated population at that time; 21.6 % of the malformations in stillbirths were those of the extremities, 14.8 % distortions of the heart, 8 % hypospadias (distortion of ureter), 7.7 % clefts (194,356 births, 739 stillbirths) | <0.3 mSv | Government of Berlin West 1987 [ |
| City of Jena | Isolated malformations | Regional registry showed increased rates 1986/1987 vs. 1985 of RR 4.1 (95% Cl, 1.16-14.56) levelling off in subseguent years; main increase in central nervous system and abdominal wall anomalies | <0.3 mSv | Lotzet al. 1996 [ |
UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation; OR, odds ratio; CI, confidence interval; Cs-137, Caesium-137; Sr-90, Strontium-90; NTD, neural tube defects; F1, first generation; GDR, German Democratic Republic; FGR, Federal German Republic; CLP, cleft lip and palate; RR, relative risk.
Mean first year committed effective doses are given by the authors or are calculated by us on the basis of information given by the authors using MicroShield and US Environmental Protection Agency FGR12 Part 2 [43] which gives the external dose rate over an infinite plane contaminated at 100 kBq/m2 as about 0.2 × 10-6 Gy h-1; we assume 16 hr/d exposure.
These doses are taken from Figures 1 and 3 of Savchenko [25] and represent the mean countrywide first year (ICRP) committed Effective Dose.
Internal doses for Cs-137 and Sr-90 calculated by us using the ICRP72 dose coefficients.
Figure 1.Down’s syndrome before and after the Chernobyl accident (A) West Berlin and (B) Belarus. From Scherb H, et al. Naturwiss Rundsch 2011;64(5):229-239, with permission from Stuttgart [47].
Congenital anomalies, especially malformations, in descendants (1st generation) of occupationally exposed men
| No. | Cohort of fathers | Kind of defect | Dose | References |
|---|---|---|---|---|
| 1 | Radiologists USA 1951 | Congenital malformations Increase 20% | Macht, et al. 1955 [ | |
| 2 | Workers of the Hanford Nuclear facility, USA | Neural tube defects significantly increased by 100% | In general <100 mSv | Sever et al. 1988 [ |
| 3 | Radiation workers at Sellafield nuclear reprocessing plant, UK | Stillbirths with neural tube defects significantly increased by 69% per 100 mSv | Mean 30 mSv | Parker et al. 1999 [ |
| 4 | Radiographers in Jordan | Congenital anomalies significantly increased 10-fold | Shakhatreh 2001 [ | |
| 5 | Liquidators from Obninsk (Russia), 300 children | Congenital anomalies increased 1994-2002 | Mainly 10-250 mSv | Tsyb et al. 2004 [ |
| 6 | Liquidators from Russia, Bryansk region | Congenital anomalies increased about 4-fold | Matveenko et al. 2006 [ | |
| 7 | Liquidators from Russia, 2379 newborns | Significant increase for: anencephaly 310%, spina bifida 316%, cleft lip/palate 170%, limb reduction 155%, multiple malformations 19%, all malformations 120% | 5-250 mSv | Lyaginskaja et al. 2009 [ |
| 8 | British nuclear test veterans | All malformations | Less than 10 mSv but internal | Urquhart 1992 [ |
| Down's syndrome | ||||
| OR 1.6 for early vs. later births | ||||
| 9 | British nuclear test veterans | All congenital conditions increased | Less than 10 mSv but internal | Roff 1999 [ |
| We estimate heart defect 4-fold | ||||
| 10 | British nuclear test veterans case control/EUROCAT study | Miscarriages odds 2.7 | Less than 10 mSv but internal | Busby et al. 2014 [ |
| Congenital conditions: children OR 9.8; grandchildren OR 8.3 |
Mean first year committed effective doses are given by the authors or are calculated by us on the basis of information given by the authors using MicroShield and US Environmental Protection Agency FGR12 Part 2 [43] which gives the external dose rate over an infinite plane contaminated at 100 kBq/m2 as about 0.2× 10-6 Gy h-1; we assume 16 hr/d exposure.
Cancer in children after preconceptional low-dose exposure of parents
| Exposed collective | Malign disease | Gonadal dose/mSv | Relative risk | Doubling dose/mSv |
|---|---|---|---|---|
| Seascale fathers [ | Leukaemia + lymphoma | |||
| All stages of spermatogenesis | 200 | 7 | 32 | |
| 6 mo before conception | 10 | 1.9 | 1.6 | |
| Further occupational exposure of fathers | ||||
| Military jobs [ | Cancer | 2.7 | ||
| Regions of UK [ | Leukaemia + lymphoma | 3.2 | ||
| Preconceptional X-ray diagnostics in | Leukaemia | |||
| Fathers 1966 [ | 1.3 | |||
| Fathers 1988 [ | 1.4-3.9 | |||
| Fathers 1994 [ | 3.8 | |||
| Mothers 1958 [ | 1.4 | 25 | ||
| Mothers 1966 [ | 1.7 | |||
| Mothers 1973 [ | 1.4 | |||
| Mothers 1980 [ | 2.6 |
Figure 2.Regions of interest in a theoretically predicted dose response relation (see text and ECRR 2010). Exactly this dose response is seen in infant leukemia rates after Chernobyl in Greece, Germany (three dose regions) Wales, Scotland and Belarus [84]. From Busby C. Aspects of DNA damage from internal radionuclides; 2013 [6]. aQ is the background cancer rate in the population at background radiation levels, the position where the graph starts.
Figure 3.Dose response for infant leukemia in the countries examined in meta-analysis of five reports in Busby 2009 [84] (UK data from Childhood Cancer Research Group Oxford). Effect is fractional excess relative risk, and dose is given by UK National Radiological Protection Board in mSv.